Dolutegravir intermediate-1
Dolutegravir intermediate-1 is a new synthetic Dolutegravir intermediate extracted from patent WO 2016125192 A2. Dolutegravir is an integrase inhibitor developed for the treatment of human immunodeficiency virus (HIV) -1 infection.
Product Specifications
CAS Number
1335210-23-5
Product Name Alternative
1- (2,2-dimethoxyethyl) -5-methoxy-6- (methoxycarbonyl) -4-oxo-1,4-dihydropyridine-3-carboxylic acid | 1- (2,2-dimethoxyethyl) -5-methoxy-6-methoxycarbonyl-4-oxopyridine-3-carboxylic acid
Field of Research
Pharmacology & Drug Discovery
Purity
>98% (HPLC)
Solubility
DMSO: 100 mg/mL (285.46 mM; Need ultrasonic)
Smiles
COC (CN (C=C (C ([O-]) =O) C1=O) C (C (OC) =O) =C1OC) OC
Molecular Formula
C13H16NO8
Molecular Weight
314.27
Storage Conditions
Storage temperature: -20°C. Stability: ≥ 2 years
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
